PHR - Public offerings

Industry Veteran Brings Track Record of Technology-Driven Growth and Value Creation Edward L. Cahill and Michael Weintraub to Retire at 2026 Annual Meeting of Stockholders Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") today announced that it has appointed Jon Kessler to its Board, effective April 6, 2026. In addition, Edward L. Cahill and Michael Weintraub have informed the Board that they will retire from the Board, effective at the 2026 Annual Meeting. Mr. Kessler is an experienced public company CEO and director who will bring valuable expertise to the Phreesia Board. As founder, Chairman and CEO of WageWorks and most recently President and CEO of HealthEquity (NASDAQ:HQY

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Kristin Roberts, Vice President of Product Management, has been named in Becker's Hospital Review's 2025 list of the 100 Women in Health IT to Know. "Women are leading the charge in transforming the future of healthcare through innovation in health IT," Becker's said in its announcement of the list. "These trailblazing leaders are streamlining administrative processes, eliminating inefficiencies, standardizing workflows and driving meaningful change across the industry." In her role, Kristin drives Phreesia's product vision and roadmap to meet the evolving needs of healthcare organizations, improve

Phreesia, Inc. (NYSE:PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia's Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities. Gandhi has over 25 years of experience as an operating executive with healthcare services and technology companies and as an investment research analyst following the space. He joined Phreesia in 2019 in preparation for its initial public offering and most recently served as Senior Vice President, Investor Relations, and a me

Phreesia is pleased to announce that Chaim Indig, Chief Executive Officer of Phreesia, has been named to The Software Report's list of the Top 50 SaaS CEOs of 2021. The annual award recognizes leaders of high-performing Software-as-a-Service companies who have demonstrated success in bringing value to their clients and leading diverse and accomplished teams. Past awardees' companies have included Cvent, Zoom and Qualtrics. Since co-founding Phreesia in 2005, Indig has helped revolutionize the healthcare experience for patients, healthcare providers and staff. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world'

Phreesia, Inc. (the "Company") (NYSE:PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,175,000 shares of its common stock (the "Offering") all of which were sold by the Company, which includes the full exercise of the underwriters' option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of $50.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount. The Company received net proceeds from the offering of approximately $245.3 million after deducting underwriting discounts and estimated offering e

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the “Offering”) at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is expected to close on April 12, 2021, subject to the satisfaction of customary closing conditions. Phreesia expects to receive net p

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the actual size and terms of the offering. J.P. Morgan and Wi